Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Swiss Cancer Institute
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
NYU Langone Health
UNC Lineberger Comprehensive Cancer Center